chrisvoncsefalvay/vaers-outcomes huggingface dataset:
little tired; scan is for my kidney or prostate, I'm not sure if the problem was there before i got the 1st dose, but it was discovered through a blood test I did after the 1st dose; scan is for my kidney or prostate, I'm not sure if the problem was there before i got the 1st dose, but it was discovered through a blood test I did after the 1st dose; This is a spontaneous report from a non-contactable consumer (patient). This male patient of unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number unknown) via an unspecified route of administration on 06Apr2021 as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient reported he received his first dose on 06Apr2021 and was schedule for his second dose on 27Apr2021. He reported that on 03May (2021) he had to go to the hospital to get magnetic resonance imaging (MRI) and computerized tomography (CT) scans done and inquired if it was okay to get the tests done after the vaccine or if he should reschedule. The patient stated that after his first dose he was just a little tired and didn't have any other side effects; further stating the MRI and CT scan were for his kidney or prostate. He was not sure if the problem was there before he got the first dose, but it was discovered through a blood test after the first dose. He also inquired if he could reschedule the vaccine. The clinical outcomes of little tired and scan is for my kidney or prostate, I'm not sure if the problem was there before I got the first dose, but it was discovered through a blood test I did after the first dose were unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Breaking out with a rash that is still breaking out, it is on her hands, arms, one leg ¨for now¨, as the caller mentioned, chest, face, "it is itching pretty bad"; Felt extra tired ,has been sleeping a lot; Breaking out with a rash that is still breaking out, it is on her hands, arms, one leg ¨for now¨, as the caller mentioned, chest, face, "it is itching pretty bad"; Headache; Felt extra tired ,has been sleeping a lot; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (Breaking out with a rash that is still breaking out, it is on her hands, arms, one leg ¨for now¨, as the caller mentioned, chest, face, "it is itching pretty bad"), HYPERSOMNIA (Felt extra tired ,has been sleeping a lot), RASH (Breaking out with a rash that is still breaking out, it is on her hands, arms, one leg ¨for now¨, as the caller mentioned, chest, face, "it is itching pretty bad"), HEADACHE (Headache) and FATIGUE (Felt extra tired ,has been sleeping a lot) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On 27-Mar-2021, the patient experienced RASH PRURITIC (Breaking out with a rash that is still breaking out, it is on her hands, arms, one leg ¨for now¨, as the caller mentioned, chest, face, "it is itching pretty bad"), HYPERSOMNIA (Felt extra tired ,has been sleeping a lot), RASH (Breaking out with a rash that is still breaking out, it is on her hands, arms, one leg ¨for now¨, as the caller mentioned, chest, face, "it is itching pretty bad"), HEADACHE (Headache) and FATIGUE (Felt extra tired ,has been sleeping a lot). At the time of the report, RASH PRURITIC (Breaking out with a rash that is still breaking out, it is on her hands, arms, one leg ¨for now¨, as the caller mentioned, chest, face, "it is itching pretty bad"), HYPERSOMNIA (Felt extra tired ,has been sleeping a lot), RASH (Breaking out with a rash that is still breaking out, it is on her hands, arms, one leg ¨for now¨, as the caller mentioned, chest, face, "it is itching pretty bad"), HEADACHE (Headache) and FATIGUE (Felt extra tired ,has been sleeping a lot) outcome was unknown.            Concomitant medicines include allergy pills, pills for depression, stomach pills, muscle relaxer. Treatment include Benadryl.
gave 10 y/o white male Menactra vaccine. Currently vaccine not approved for age group
runny nose; tickle in my throat; occasional cough; COVID-19 positive; This spontaneous case was reported by a health care professional and describes the occurrence of RHINORRHOEA (runny nose), THROAT IRRITATION (tickle in my throat), COUGH (occasional cough) and SARS-COV-2 TEST POSITIVE (covid-19 positive) in a 47-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     No Medical History information was reported.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced SARS-COV-2 TEST POSITIVE (covid-19 positive). On an unknown date, the patient experienced RHINORRHOEA (runny nose), THROAT IRRITATION (tickle in my throat) and COUGH (occasional cough). At the time of the report, RHINORRHOEA (runny nose), THROAT IRRITATION (tickle in my throat), COUGH (occasional cough) and SARS-COV-2 TEST POSITIVE (covid-19 positive) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Jan-2021, SARS-CoV-2 test: (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
This spontaneous report was received from a Nurse refers to a patient of unknown age. On an unknown date, the patient was vaccinated with VARIVAX (Merck) (dose, route and frequency were not reported). The nurse reported that one of the facilities records the temperature of their freezer storing VARIVAX (Merck) only once or twice a week. The nurse stated that from 16-NOV-2013 to 29-JAN-2014, when the temperature was recorded, it was 6F. The nurse stated that it was not confirmed the overall average temperature of the freezer has been between -58F and 5F. On an unknown date, improperly stored VARIVAX (Merck) have been administered to patients. The nurse reported that he will provide the lot number and expiration dates of the doses and as well as dates of placement of the doses of product into the freezer and dates of administration of the doses to the patient. No adverse effect was unknown. This case is linked to the case 1402USA007996 (same reporter link). Additional information has been requested.
Initial swelling/redness and pain. Several hours later experienced nausea, sweating and vomiting.
Severe gout flare in left foot.; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old male patient received his second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: Ep6955) via an unspecified route of administration in the left arm on 29Mar2021 (at the age of 36-year-old) at 18:30 as a single dose for COVID-19 immunisation. Medical history included gout and psoriasis. Concomitant medications included colchicine (MANUFACTURER UNKNOWN) from an unknown date and dietary supplements from an unknown date for an unknown indication. The patient was allergic to penicillin and aspirin. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: En6206) via an unspecified route of administration in the left arm on 08Mar2021 (at the age of 36-year-old) at 19:15 as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. On 30Mar2021 at 07:30, 13 hours after the vaccination, the patient experienced a severe gout flare in the left foot. The event resulted in a doctor or other healthcare professional office/clinic visit. The patient was treated with colchicine for the reported event. The clinical outcome of the event gout flare was not recovered at the time of the report.  No follow-up attempts are needed. No further information is expected.
Severe chest pain so much to wake patient from sleep. Hot flashes. NSAIDs were used to treat symptoms.
This spontaneous report was received from a healthcare student refers to a patient of unknown demographics. On 26-MAR-2015 the patient was administered with an expired dose of PNEUMOVAX 23 (lot # unspecified, expiry date: November 2014). No adverse effects were reported. Outcome of the event was unknown. Reporting healthcare student considered the event to be not related to PNEUMOVAX 23. Additional information has been requested.
- Itching/prickling/tingling sensation started in lower left leg and quickly spread to both legs, arms, chest, and back - Strange sensation on left side of the face?feels like something is lightly brushing against it when nothing is  - Symptoms eased up ~60% in the first month but have never fully gone away. Has been nearly 2 years.
Atrial fibrillation; Tachycardia; cataract surgery; This spontaneous case was reported by a consumer and describes the occurrence of ATRIAL FIBRILLATION (Atrial fibrillation) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 30-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ATRIAL FIBRILLATION (Atrial fibrillation) (seriousness criterion medically significant), TACHYCARDIA (Tachycardia) and CATARACT OPERATION (cataract surgery). At the time of the report, ATRIAL FIBRILLATION (Atrial fibrillation), TACHYCARDIA (Tachycardia) and CATARACT OPERATION (cataract surgery) outcome was unknown.            No Concomitant medications were reported.  It was reported that the side effect of the Moderna vaccine were related to her heart. She had atrial fibrillation and tachycardia that she takes medicine for. And due to some cataract surgery she did not realize she was having some effects from the vaccine, but she had.  No treatment medications were reported.  Company Comment: This case concerns a female patient of an unknown age with no relevant medical history, who experienced the unexpected event of Atrial Fibrillation. The event occurred on an unknown date after receiving the second dose of mRNA-1273 Vaccine. The rechallenge was not applicable since only information about the second dose was disclosed. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.   Most recent FOLLOW-UP information incorporated above includes: On 12-Nov-2021: Followup  received on 15-11-2021 and does not contain any new information.; Sender's Comments: This case concerns a female patient of an unknown age with no relevant medical history, who experienced the unexpected event of Atrial Fibrillation. The event occurred on an unknown date after receiving the second dose of mRNA-1273 Vaccine. The rechallenge was not applicable since only information about the second dose was disclosed. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.
Information has been received from a health professional concerning a 8 year old male  with NKDA who on 10/21/1996 was vaccinated with a dose of varicella virus vaccine live. On 08/10/2004 the pt experienced a breakthrough. Unspecified medical attention was sought and no lab diagnostic studies were performed. There was no product quality complaint involved. Additional information has been requested.
I had a 102 fever body aches slight headache and chills  I took Tylenol and that took care of the fever and headache chills went away still have some body aches
The vaccine was administered subcutaneously. The patient did not experience any adverse effects except for arm soreness.
This case was reported by a pharmacist and described the occurrence of arm pain in a 73-year-old male subject who was vaccinated with FLULAVAL (GlaxoSmithKline). Concurrent medications included LORTAB, Ferrous sulfate, Nadolol and Omeprazole. On 2 October 2009 the subject received unspecified dose of FLULAVAL (.5 ml, unknown, right arm). At an unspecified time after vaccination with FLULAVAL, the subject experienced arm pain. At the time of reporting the event was unresolved. The pharmacist considered the event was possibly related to vaccination with FLULAVAL. On 15 October 2009, the pharmacist reported that the subject received the FLULAVAL injection on Friday, 02 October 2009. The following Monday, 05 October, the pharmacy received a call from the subject complaining of pain down his arm, the same arm in which he received the injection. However, he does not know when the pain actually started. The pain in the muscle and radiates all the way down from his bicep to his elbow. The reporter recommended an over the counter pain reliever but he does not believe the subject took anything. He said that the subject is still complaining about the pain.
Patient complained of diaphoresis and dizziness. At 1803, BP 111/71, HR 60, R 14, O2 sat 97%, T 98.0. Patient was taken to another  room to lay down on a stretcher. Patient was given water. BP 116/74, HR 59, R 16, O2 sat 99%, T 97.5. After, patient stated he was feeling fine and was able to stand for 2 minutes without dizziness. Patient was discharged to father.
Broke out in hives/rash on the front of my neck.  It was itchy and I treated it with Hydrocortizone.  This initially started on 05/03/2021 and as of today, 05/05/2021 the hives are still present. On the date of the 2nd vacination i felt totally exhausted and felt like I hit a wall withing 4 hours of receiving he 2nd vaccine.  This reaction was more pronounced than after the 1st vaccine.  This went on for 3 days.  I am still experiencing being very tired.  I also had a metalilc taste in my mouth on the first day after the 2nd vaccine that lasted for a week.
Had what acted like an MS flare after most recent full dose #3 (full dose because immunocompromised with B cell depleting agent Ocrevus for MS) with worse dizziness, worse balance, worse spasticity and profound fatigue beginning 1-2 days after vaccination and lasting 3-4 weeks.  This happened after dose #2 as well beginning on 4/24/21
Medical Assistant administered a dose of Engerix-B to a 65 year old male patient on 20Sep2023 from lot 7XY23, which had an expiration date of 29Apr2023; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 65-year-old male patient who received HBV (Engerix B) (batch number 7XY23, expiry date 29-APR-2023) for prophylaxis.   On 20-SEP-2023, the patient received the 1st dose of Engerix B. On 20-SEP-2023, an unknown time after receiving Engerix B, the patient experienced expired vaccine used (Verbatim: Medical Assistant administered a dose of Engerix-B to a 65 year old male patient on 20Sep2023 from lot 7XY23, which had an expiration date of 29Apr2023).  The outcome of the expired vaccine used was unknown.   Additional Information: GSK Receipt Date: 20-SEP-2023 Nurse reports that a Medical Assistant administered a dose of Engerix-B patient on 20th September 2023 which had an expiration date of 29th April 2023 which led to expired vaccine used.  This was the patient's first dose in the series. At the time of reporting, the dose has not been repeated. The reporter consented to follow up. The vaccine administration facility is the same as primary reporter.
I am a RN working at a hospital where we are required to receive a flu shot. Every year I develop iritis 2 weeks after receiving the vaccination. At first I have tenderness and some light sensitivity. The pain increases rapidly if untreated. I begin PRED-FORTE eye drops ASAP. The first time I had a flu shot the pain and photophobia was so severe the eye doctor dilated my pupils and injected a steroid into the eye chamber. At 1st it was in left eye each year - this year it was both.
75 Y  male with history of glioblastoma multiforme, metastatic prostate CA (with diffuse mets to RP lymph nodes, bone), DM2, HLD, HTN, hx of CVA with residual left sided deficits, now admitted for ACUTE HYPOXEMIC RESPIRATORY FAILURE 2/2 COVID PNA   Presented from SNF with dyspnea, hypoxia, needing 4L NC. Tested positive for COVID on 11/8/21.  Also found to have acute pulm embolism.    Started on anticoagulation for PE.  Completed remdesevir x 5 days on 11/25/21.  Continued on decadron for hx of GBM.  Able to wean to RA.  Per ID - completed COVID isolation on 11/28/21 and de-isolated starting 11/29/21.    Transitioned over to eliquis for PE.  Patient did not have further resp decompensation but did have uptrending leukocytosis with subtle LLL opacity on CXR on 11/27/21.  Started empirically on moxifloxacin for presumed superimposed bacterial PNA.  Will complete 7 day course on 12/3/21.    Otherwise stable thru hospital course.  On evaluation of goals of care - wants to continue with GBM therapy.  Dr (neuroonc) proposed likely radiation monotherapy.    DC to SNF.  Continue moxi as above.  Eliquis to switch to 5 mg PO BID on 12/7/21 as maintenance for pulm embolism. Cont PTA decadron 4 mg daily.    Holding zytiga as cannot be crushed and patient on pureed diet with crushed meds. Can r/s when able to take pills whole.    Primary Procedures:  None   Secondary Procedures: None   Reason for Hospital Admission (Admitting Diagnosis):  ACUTE HYPOXEMIC RESPIRATORY FAILURE
pt presented as well child in office for 2mo well check w/o problems & was given vax;that same evening, pt cried inconsolably for approx 3hr;lt leg where immun given warm & tender through the evening;no elevated temp documented;no pertussis
Extremely painful at time of injection and still cannot lift arm without extreme pain and arm and fingers go numb.
16 year old patient inadvertently received their 1st Moderna vaccine; This spontaneous case was reported by a patient and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old patient inadvertently received their 1st Moderna vaccine) in a 16-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse reaction.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old patient inadvertently received their 1st Moderna vaccine). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old patient inadvertently received their 1st Moderna vaccine) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Nine days post vaccine, injection site has large (approx. 2x3 inches oval) red welp.  Shoulder, arm, upper back is weak, warm, and achy.
Patient complains of "significant" pain in deltoid from PNEUMOVAX shot on 9/29/16.
This case was reported by a pharmacist via call center representative and described the occurrence of productive cough in a 58-year-old female patient who received BOOSTRIX (batch number X7DN3, expiry date 31st August 2017. On 16th February 2016, the patient received BOOSTRIX. On 16th February 2016, immediately after receiving BOOSTRIX, the patient experienced productive cough. On an unknown date, the outcome of the productive cough was unchanged. It was unknown if the reporter considered the productive cough to be related to BOOSTRIX.
Inappropriate schedule of vaccine administered.  Initial information received on 25 August 2009 from a health care professional.  A male patient with an unknown past medical history experienced a reaction after he received a second dose of MENACTRA (lot number not known) on either 19 August 2009 or 20 August 2009.  One day post vaccination the patient developed dizziness.  On 25 August 2009 the patient complained of continued severe vertigo.  The patient reported receiving a first dose of MENACTRA one year prior without a reaction.  At the time of the report the patient was not recovered.  List of Documents held by Sender: none.
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and genders. The reporter stated that, on an unspecified date, an unknown number of doses of LIQUID PEDVAXHIB (dose, lot#, expiration dates not provided) that were stored at 48 degrees F for 20 minutes, then exposed to 47 degrees for 9 minutes have been administered. No adverse effects were reported. Follow up information has been received on 22-JUL-2014 from a receptionist. The reporter stated that there were two different lot number of LIQUID PEDVAXHIB that were included in the temperature excursion: Lot # J016188, expiration date: 02-OCT-2016 and lot # J015437, expiration date: 09-OCT-2016. The receptionist did not have any additional information to share. Follow-up information has been received from the registered nurse who provided patients details. The report refers to a 9 weeks old infant patient of unknown gender. On 11-JUN-2014 the patient was vaccinated with a dose of LIQUID PEDVAXHIB (dose and route were not reported, lot# J015437, expiration date: 09-OCT-2016) that was improperly stored. No adverse effects were reported. This is the one of several reports received from the same reporter. Additional information is not expected.
Arm pain and headaches at 1:30pm on February 4, 2021.
rec'd vaccine on 12/3/2020 returned to pharmacy on 12/7/2020 after visiting MD who asked him to go to pharmacy with warm/hot arm, redness about 5 inches down his arm.
Patient is fully vaccinated. DX: SoB, hypoxia, respiratory distress, pneumonia due to COVID.Pt tested positive for COVID on home test on 1/4. EMS reported that he was hypoxic at 79% on initial arrival. Placed on non-rebreather with improvement. ER workup showed NSTEMI with troponins elevated at 0.22. Pt started on Heparin gtt. Pt started on empiric antibiotics. CXR showed mild CHF. D dimer 1226.Cr 2.72. Patient seen by cardio and ID.  Placed on remdesivir and decadron.  Oxygen weaned down and discharged.
I was extremely fatigue with headache and muscle ache from 5 am  to 9 pm on Dec 1. Then I felt fine. But my period started on Dec 4, which is 2 weeks earlier than my regular cycle. My period is regular with a 30 day cycle. My last period started on Nov 18.
Redness and slight warmth at injection site  Narrative:  Vitals: 1629 BP: 118/81, P: 73, O2: 97% Vitals: 1634 BP: 122/84, P: 79, O2: 98%